Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006;8(2):151-3.
doi: 10.1080/13651820410016705.

Cholangiocarcinoma, renal cell carcinoma and parathyroid adenoma found synchronously in a patient on long-term methotrexate

Affiliations

Cholangiocarcinoma, renal cell carcinoma and parathyroid adenoma found synchronously in a patient on long-term methotrexate

B F Levy et al. HPB (Oxford). 2006.

Abstract

Cases of patients developing lymphoma and cutaneous neoplasms after long-term methotrexate therapy are well documented in the literature; however, there are no reported cases of other neoplasms resulting from methotrexate therapy. A 52-year-old woman who had been on methotrexate for 9 years for psoriatic arthritis was found to have abnormal liver function tests on screening. Investigation with ultrasound, CT scanning and MRCP showed a hilar cholangiocarcinoma and a synchronous right renal tumour. A left hemi-hepatectomy extended to segments 5 and 8 with the formation of a hepaticojejunostomy was performed for a poorly differentiated infiltrative hilar cholangiocarcinoma. This was combined with a right radical nephrectomy for a T1 renal cell adenocarcinoma. Postoperative vomiting was subsequently found to be due to hypercalcaemia and primary hyperparathyroidism. A parathyroid adenoma was later excised. It seems likely that treatment with methotrexate was causal in the development of these three non-cutaneous neoplasms-two malignant and one benign.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
MRCP scan showing dilatation of the left intrahepatic ducts.
Figure 2.
Figure 2.
Hilum and underside of extended left hepatectomy specimen.

Similar articles

Cited by

References

    1. Kremer JM. Methotrexate update. Scand J Rheumatol. 1996;25:341–4. - PubMed
    1. West SG. Methotrexate hepatotoxicity. Rheum Dis Clin North Am. 1997;23:883–915. - PubMed
    1. Coleiro B, Mallia C. Toxicity profile of methotrexate in rheumatoid arthritis. A preliminary survey. Adv Exp Med Biol. 1999;455:359–65. - PubMed
    1. Dufour JF, Kaplan M. Methotrexate therapy and liver disease. N Engl J Med. 1996;335:898–9. - PubMed
    1. Stern RS, Laird N. The carcinogenic risk of treatments for psoriasis. Photochemotherapy follow-up study. Cancer. 1994;73:2759–64. - PubMed